← Open Payments lookup

AMY MEUSBORN: Open Payments

NPI 1962630871 · MANHATTAN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$643 in 31 payments from 11 companies in 2025. Trend: 2023 $840 · 2024 $783 · 2025 $643

Food & beverage: $565Education: $78
CompanyPaymentsAmount
Janssen Biotech, Inc.7$178
ABBVIE INC.11$136
Sumitomo Pharma America, Inc.2$99
PFIZER INC.3$73
180 Medical, Inc.2$52
UROGEN PHARMA, INC.1$23
Takeda Pharmaceuticals U.S.A., Inc.1$19
Teleflex LLC1$19
Boston Scientific Corporation1$15
TOLMAR, INC.1$14

Products named: ERLEADA, GEMTESA, LUPRON DEPOT, XTANDI, BOTOX, EOHILIA, UROLIFT, RYBREVANT.

Industry payments across KS — which companies pay providers there.